First patient enrolled in a Phase III study with QUTENZA in post-surgical neuropathic pain
- The study AV001 aims to include the treatment of post-surgical neuropathic pain (PSNP) in the U.S. label - QUTENZA is currently approved for use in adults in the treatment of neuropathic
Source: finanznachrichten.de